Beam Therapeutics (BEAM) Non-Current Deferred Revenue (2020 - 2025)
Beam Therapeutics (BEAM) reported Non-Current Deferred Revenue of $10.16 million for Q3 2025, down 82.4% from $57.82 million a year earlier and down 50.0% from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Non-Current Deferred Revenue (2020 - 2025) Analysis & Trends
At the end of FY2024, Beam Therapeutics posted Non-Current Deferred Revenue of $33.22 million, down 69.8% from FY2023.
- Non-Current Deferred Revenue has declined for three consecutive years, though with a four-year compound annual growth rate of 203.0% (FY2020 to FY2024).
- By year, Non-Current Deferred Revenue came in at $109.89 million in FY2023 (-45.6%), $202.18 million in FY2022 (-22.9%), $262.3 million in FY2021 and $394,000 in FY2020.
- The Q3 2025 figure ranks as the lowest quarterly Non-Current Deferred Revenue since Q4 2020.
- Year over year, Non-Current Deferred Revenue has now declined in each of the last 12 quarters, with an average decline of 58.6% over the last eight quarters.
- The high point for year-over-year Non-Current Deferred Revenue in five years was Q3 2022 (growth of 438.5%); the low point was Q3 2025 (a decline of 82.4%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $20.32 million (Q2 2025), $49.4 million (Q1 2025) and $33.22 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Beam Therapeutics | 2.60 Bn | -2.05 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 10.16 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Mar 31, 2025 | 49.40 Mn |
| Dec 31, 2024 | 33.22 Mn |
| Sep 30, 2024 | 57.82 Mn |
| Jun 30, 2024 | 75.49 Mn |
| Mar 31, 2024 | 99.57 Mn |
| Dec 31, 2023 | 109.89 Mn |
| Sep 30, 2023 | 124.65 Mn |
| Jun 30, 2023 | 156.20 Mn |
| Mar 31, 2023 | 171.71 Mn |
| Dec 31, 2022 | 202.18 Mn |
| Sep 30, 2022 | 198.29 Mn |
| Jun 30, 2022 | 208.82 Mn |
| Mar 31, 2022 | 225.09 Mn |
| Dec 31, 2021 | 262.30 Mn |
| Sep 30, 2021 | 36.82 Mn |
| Jun 30, 2021 | 40.38 Mn |
| Dec 31, 2020 | 394,000.00 |
API Access
Beam Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();